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Purpose: The estimation of regional lymph node metastasis (LNM) risk in T1 
colorectal cancer is based on histologic examination and imaging of the primary 
tumor. High-frequency microsatellite instability (MSI-H) is likely to decrease the 
possibility of metastasis to either regional lymph nodes or distant organs in 
colorectal cancers. This study evaluated the clinical implications of MSI in T1 
colorectal cancer with emphasis on the usefulness of MSI as a predictive factor for 
regional LNM. Materials and Methods: A total of 133 patients who underwent 
radical resection for T1 colorectal cancer were included. Genomic DNA was ex-
tracted from normal and tumor tissues and amplified by polymerase chain reaction 
(PCR). Five microsatellite markers, BAT-25, BAT-26, D2S123, D5S346, and 
D17S250, were used. MSI and clinicopathological parameters were evaluated as 
potential predictors of LNM using univariate and multivariate analyses. Results: 
Among 133 T1 colorectal cancer patients, MSI-H, low-frequency microsatellite 
instability (MSI-L), and microsatellite stable (MSS) colorectal cancers accounted 
for 7.5%, 6%, and 86.5%, respectively. MSI-H tumors showed a female predomi-
nance, a proximal location and more retrieved lymph nodes. Twenty-two patients 
(16.5%) had regional LNM. Lymphovascular invasion and depth of invasion were 
significantly associated with LNM. There was no LNM in 10 MSI-H patients; 
however, MSI status was not significantly correlated with LNM. Disease-free sur-
vival did not differ between patients with MSI-H and those with MSI-L/MSS. 
Conclusion: MSI status could serve as a negative predictive factor in estimating 
LNM in T1 colorectal cancer, given that LNM was not detected in MSI-H pa-
tients. However, validation of our result in a different cohort is necessary.
Key Words:   Microsatellite instability, lymph node metastasis, early colorectal 
cancer, T1, prognosis
INTRODUCTION
Although the basic principle in surgical management of colorectal cancer is wide 
resection of the primary tumor and adequate regional lymph node dissection, some 
modifications are appropriate in selected patients. When the cancer is confined to 
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Patients who underwent curative resection for T1 colon or 
rectal adenocarcinoma between January 2005 and May 
2011 were selected from our prospectively collected data-
base. Excluded from the initial selection were patients who 
had undergone preoperative chemotherapy or radiotherapy, 
patients who were diagnosed with HNPCC or a familial ad-
enomatous polyposis, patients who underwent transanal ex-
cision, and patients initially diagnosed with stage IV dis-
ease. The inclusion of patients was based on the availability 
of MSI data, as well as a complete set of clinicopathologi-
cal information including age, sex, tumor size, histologic 
grade, lymphovascular invasion, depth of invasion, date of 
surgery, location of the primary tumor, [proximal colon (ce-
cal, ascending, or transverse colon), distal colon (descend-
ing, sigmoid, or rectosigmoid colon), or rectum], date of re-
currence, pathologic nodal stage, and total retrieved lymph 
nodes. After exclusions, 133 patients were included in our 
analysis. This study was approved by our Institutional Re-
view Board (number: 4-2010-0286).
Sectioning and microdissection
Genomic DNA was extracted from three to five sections of 
10-μm-thick formalin-fixed, paraffin-embedded tissue 
blocks containing tumor and non-neoplastic mucosa using a 
QIAamp DNA mini kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s protocol. Separate blocks were 
used for malignant and non-malignant tissue. Tumor blocks 
with a tumor area greater than 80% tumor cells were select-
ed based on hematoxylin and eosin stained slides. 
Microsatellite instability (MSI)
The MSI status of each tumor was determined with the fol-
lowing five markers: BAT 25, BAT 26, D2S123, D5S346, 
and D17S250. Fifty nanograms of DNA were amplified in 
a 20 μL reaction solution containing 2 μL of 10X buffer 
(Roche, Mannheim, Germany), 1.7 to 2.5 mmol/L of MgCl2, 
0.3 μM of each primer pair, 250 μM of deoxynucleotide tri-
phosphate, and 2.5 units of DNA polymerase (Roche). The 
primer sequences and polymerase chain reaction (PCR) cy-
cles for each marker were adapted from the published data.25 
Fluorescence markers (NED, FAM) were attached to the 5’ 
the mucosal layer, the tumor can be completely removed by 
an endoscopic procedure or local excision and further lymph 
node dissection is not necessary since there is no risk of 
lymph node metastasis (LNM) in these cancers. The same 
treatment strategy could be applied to invasive carcinoma if 
the risk of LNM could be predicted. However, the challenge 
in applying local resection to invasive carcinoma is predict-
ing the presence of LNM. The risk of regional LNM increas-
es in proportion to the depth of invasion. The overall LNM 
rate of T1 colorectal cancer was reported to range from 6% 
to 13%,1-4 which is relatively low compared to 19‒28% for 
T2 and 36‒65.4% for T3 and T4 cancer.5-7 
Currently, when a tumor is found to be confined within the 
submucosa during a preoperative workup, resection of the 
primary tumor is attempted. The possibility of LNM is sub-
sequently evaluated based on histologic examination of the 
primary tumor with regard to features such as depth of inva-
sion, presence of lymphovascular invasion, differentiation, 
and tumor budding.8 It is recommended that patients at high 
risk undergo radical resection due to the possibility of region-
al LNM. Given that the development of colorectal cancer is 
known to be the result of accumulating genetic alterations,9-11 
it seems prudent to take into account histologic features of 
the primary tumor in addition to molecular biological charac-
teristics for the prediction of regional LNM in T1 colorectal 
cancer. However, to the best of our knowledge, there are lim-
ited reports on predicting regional LNM in T1 colorectal can-
cer using molecular biological characteristics.12
MSI is one of the prevalent carcinogenic pathways in 
colorectal cancer, caused by a mismatch repair gene defect 
resulting in loss or gain of tandem repeat sequences.13-16 A 
high frequency of microsatellite instability (MSI-H) has 
been found in most patients with hereditary nonpolyposis 
colorectal cancer (HNPCC), and occurs in approximately 
15% of sporadic colorectal cancer cases.15-18 MSI-H tumors 
were associated with unique clinicopathological characteris-
tics, such as younger age at onset, proximal location, and 
frequent peritumoral lymphocytic infiltration.19-21 Addition-
ally, MSI-H tumors showed a lower incidence of LNM and 
a better survival rate.21-24 Most previous studies investigat-
ing the relationship between MSI and regional LNM were 
based on advanced colorectal cancers. However, little is 
known regarding the specific impact of MSI in early 
colorectal cancer.
Therefore, the aim of this study was to evaluate the clini-
cal implications of MSI in T1 colorectal cancer with em-
phasis on the usefulness of MSI as a predictive factor for 
MSI in T1 Colorectal Cancer
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 177
together and denoted as MSI-L/MSS. Comparisons of clin-
icopathological characteristics between the MSI-H and 
MSI-L/MSS groups are summarized in Table 2. There was 
a female predominance in the MSI-H group (p=0.005). The 
predominant location in the MSI-H group was the proximal 
colon (p=0.001). There was no significant difference be-
tween the two groups with regard to the depth of tumor in-
vasion, histologic grade, presence of lymphovascular inva-
sion, or tumor size. In contrast, the number of total 
retrieved lymph nodes was higher in the MSI-H group 
(p=0.044). The number of metastatic lymph nodes in the 
MSI-H group was significantly lower in comparison to the 
MSI-L/MSS group (p<0.001).
end of the forward primer.
All samples were prepared for fragment separation on an 
ABI Prism 3100 Genetic Analyzer using 0.7 μL of the am-
plified samples combined with 0.3 μL of GeneScan 500 
Size Standard and 9 μL of HiDi Formamide.
MSI was diagnosed when there were aberrant peaks or 
peak shifts compared to the normal control. A case was cate-
gorized as MSI-H if MSI was present at two or more mark-
ers, MSI-low (MSI-L) if only one of the five markers showed 
instability, and microsatellite stable (MSS) if no marker had 
evidence of MSI.26 In all of the analyses, MSI-L, and MSS 
tumors were grouped together and denoted as MSI-L/MSS.
Statistical analysis
All calculations and analyses were performed using SPSS 
version 20.0 (SPSS Inc., Chicago, IL, USA). The associa-
tion of clinicopathological features with MSI status was an-
alyzed using the two-sided Pearson’s chi-square test or 
Fisher’s exact test for categorical variables and Student’s t-
test for continuous variables. Factors associated with LNM 
were analyzed by logistic regression with forward stepwise 
selection of variables. Disease-free survival (DFS) was de-
fined as the time from the date of operation to the date of 
tumor recurrence or last follow-up. Survival analysis was 
performed with the Kaplan-Meier method. The log-rank 
test was used to compare survival outcome between groups. 





Patients’ characteristics are summarized in Table 1. The 
median age was 60 years (range: 32‒84 years). The distri-
bution of tumor locations was as follows: 29 in the proxi-
mal colon, 32 in the distal colon and 72 in the rectum. 
Twenty-two patients (16.5%) had regional LNM. Histolog-
ic grade examination revealed only one patient (0.8%) with 
poorly differentiated adenocarcinoma. The distribution of 
invasion was 47 sm1, 35 sm2, and 51 sm3. Lymphovascu-
lar invasion was detected in 18 patients (13.5%). The medi-
an tumor size was 1.9 cm (range: 0.2‒8.0 cm). 
Clinical characteristics of patients with MSI 
An evaluation of tumor MSI status revealed MSS in 115 
patients (86.5%), MSI-L in 8 patients (6.0%) and MSI-H in 
10 patients (7.5%). MSI-L and MSS tumors were grouped 
Table 1. Patient Baseline Characteristics
n (%)
Gender
    Male   73 (54.9)
    Female   60 (45.1)
Age (yrs)
    Median (range)   60 (32–84)
Preoperative CEA (ng/mL)
    Median (range)  1.4 (0.0–9.8)
Tumor location
    Proximal colon   29 (21.8)
    Distal colon   32 (24.1)
    Rectum   72 (54.1)
Depth of invasion
    Sm1   47 (35.3)
    Sm2   35 (26.3)
    Sm3   51 (38.3)
pN
    Node negative 111 (83.5)
    Node positive   22 (16.5)
LN numbers
    <12   48 (36.1)
    ≥12   85 (63.9)
Histologic grade*
    G1   46 (34.6)
    G2   86 (64.7)
    G3     1 (0.8)
LVI
    Negative 115 (86.5)
    Positive   18 (13.5)
Tumor size (cm)
    Median (range)  1.9 (0.2–8.0)
CEA, carcinoembryonic antigen; LN, lymph node; LVI, lymphovascular inva-
sion.
*Histologic grade: G1, well differentiated; G2, moderately differentiated; 
G3, poorly differentiated.
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er’s exact test). However, there was no LNM in the MSI-H 
group (Table 3).
Survival analysis 
We compared disease-free survival between patients with 
MSI-H and those with MSI-L/MSS (Fig. 1). There was no 
significant difference in three-year DFS between the two 
groups (100% in the MSI-H group; 93.7% in the MSI-L/
MSS group; p=0.542) (Fig. 1). 
Factors associated with LNM
Histologic grade, lymphovascular invasion, and depth of in-
vasion were significantly associated with LNM by univariate 
analysis. Multivariate analysis indicated that lymphovascular 
invasion [hazard ratio (HR), 17.2; 95% confidence interval 
(CI), 4.8‒61.0; p<0.001] and depth of invasion (comparing 
sm1 to sm3: HR, 4.4; 95% CI, 1.1‒16.9; p=0.030) were in-
dependent risk factors for LNM. MSI-H was not correlated 
with regional LNM by univariate analysis (p=0.213, Fish-
Table 2. Comparison of Clinicopathological Characteristics between MSI-H Group and MSI-L and MSS Group
MSI-H group (%) MSI-L and MSS group (%) p value
Gender
    Male      1 (10)    72 (58.5)   0.005*
    Female      9 (90)    51 (41.5)
Age (yrs)
    Mean (SD) 59.3 (9.4) 59.9 (10.1)   0.841
Preoperative CEA (ng/mL)
    Mean (SD)   1.5 (1.3)   1.7 (1.5)   0.815
Tumor location
    Proximal colon      7 (70)    22 (17.9)   0.001*
    Distal colon      0 (0)    32 (26.0)
    Rectum      3 (30)    69 (56.1)
Depth of invasion
    Sm1      2 (20)    45 (36.6)   0.502*
    Sm2      4 (40)    31 (25.2)
    Sm3      4 (40)    47 (38.2)
pN
    N negative    10 (100)  101 (82.1)   0.213*
    N positive      0 (0)    22 (17.9)
LN numbers
    <12      1 (10)    47 (38.2)   0.094*
    ≥12      9 (90)    76 (61.8)
No. of metastatic LNs
    Mean (SD)      0   0.3 (0.7) <0.001
No. of retrieved LNs
    Mean (SD) 24.9 (12.1) 16.1 (13.1)   0.044
Histologic grade†
    G1      2 (20)    44 (35.8)   0.531*
    G2      8 (80)    78 (63.4)
    G3      0 (0)      1 (0.8)
LVI
    Negative      9 (90)  106 (86.2)   1.0*
    Positive      1 (10)    17 (13.8)
Tumor size (cm)
    <2.0      9 (90)    82 (66.7)   0.169*
    ≥2.0      1 (10)    41 (33.3)
CEA, carcinoembryonic antigen; LN, lymph node; LVI, lymphovascular invasion; SD, standard deviation; MSI-H, high-frequency microsatellite instability; 
MSI-L, low-frequency microsatellite instability; MSS, microsatellite stable.
*Fisher’s exact test.
†Histologic grade: G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated.
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aging and histologic characteristics of the primary tumor 
such as depth of tumor invasion, tumor differentiation and 
lymphovascular invasion.8 In current practice, even after 
complete removal of the primary tumor, an additional radi-
cal resection is recommended for patients found to have 
high LNM risk upon histologic examination. However, a 
large-scale multicenter study found that the actual rate of 
LNM was only 14‒23% according to respective high risk 
factors.1 For this reason, a great deal of effort has gone into 
reducing potential over-treatment by precise prediction of 
LNM risk. 
In this study, the role of MSI was investigated as one of 
the predictive factors for LNM in T1 colorectal cancer, since 
we feel that in the prediction of early metastasis, biological 
DISCUSSION
The major finding of this study was that MSI status could be 
used as a negative predictive marker in estimating LNM in 
T1 colorectal cancer given that there was no LNM in MSI-
H patients.
The standard treatment for colorectal cancer is complete 
resection of the primary tumor with regional lymphadenec-
tomy due to the potential risk of regional LNM. However, 
in T1 colorectal cancer, regional lymphadenectomy can be 
omitted without deterioration of oncologic outcomes for se-
lected patients with little risk of regional LNM. The predic-
tion of regional LNM was made based on preoperative im-
Table 3. Factors Associated with Lymph Node Metastasis in T1 Colorectal Carcinoma
Univariate Multivariate
(%) p value HR (95% CI) p value
Gender
    Male     10/73 (13.7)   0.330 N/A
    Female     12/60 (20.0)
Age (yrs)
    <60     11/61 (18.0)   0.670 N/A
    ≥60     11/72 (15.3)
Tumor location
    Proximal colon       3/29 (10.3)   0.405* N/A
    Distal colon & rectum   19/104 (18.3)
Preoperative CEA (ng/mL)
    <5.0   21/129 (16.3)   0.519* N/A
    ≥5.0         1/4 (25.0)
Histologic grade†
    G1     3/46 (6.5)   0.024 N/S N/S
    G2 & G3     19/87 (21.8)
LVI
    Negative 11/115 (9.6) <0.001* 1 <0.001
    Positive     11/18 (61.1) 17.2 (4.8–61.0)
Tumor size (cm)
    <2.0     17/91 (18.7)   0.328 N/A
    ≥2.0       5/42 (11.9)
Depth of invasion
    Sm1     4/47 (8.5)   0.007 1   
    Sm2     3/35 (8.6) 0.7 (0.1–4.1)    0.710
    Sm3     15/51 (29.4)   4.4 (1.1–16.9)   0.030
Microsatellite status
    MSI-H 0 /10 (0)   0.213* N/A
    MSI-L & MSS   22/123 (17.9)
CEA, carcinoembryonic antigen; LVI, lymphovascular invasion; N/A, not applicable; N/S: non significant; HR, hazard ratio; CI, confidence interval; MSI-H, 
high-frequency microsatellite instability; MSI-L, low-frequency microsatellite instability; MSS, microsatellite stable.
Factors with p value less than 0.2 in univariate analysis were entered into multivariate analysis.
*Fisher’s exact test.
†Histologic grade: G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated.
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colon cancer and not in stage II colon cancer, the associa-
tion was not evident in stage III colorectal cancer in another 
series.33 It was reported that this discrepancy might have 
originated from different uses of panels in defining MSI-H, 
different incidences of MSI-H phenotype, and limited num-
bers of MSI-H cases.26,34 In our study, although the frequency 
of MSI-H was relatively low (7.5%), a higher lymph node 
harvest was observed in MSI-H tumors (p=0.044), confirm-
ing the positive correlation of MSI-H and retrieved lymph 
node numbers. In the sub-group analysis of stage I patients 
(n=111), there was still a trend toward increased total re-
trieved lymph nodes in MSI-H tumors (MSI-H: mean of 
24.9; MSI-L/MSS: mean of 16; p=0.062; data not shown).
The incidence of regional LNM was 16.5% in the current 
study, higher than in previous reports (6.3% to 13%).1-4 
This difference may be the result of patient selection bias in 
this study. Most of the included patients were candidates 
for radical surgery because of the presence of risk factors 
for regional LNM or technical factors such as incomplete 
resection or difficulty in complete resection of the primary 
tumor. These factors could have contributed to the relative-
ly high incidence of regional LNM; however, the fact that 
all included patients underwent radical surgery is a unique 
aspect of this study. For this reason, the presence of cancer 
metastasis to regional lymph nodes was confirmed by patho-
logical examination. It is also noteworthy that there was no 
regional LNM in patients with MSI-H, even among high 
risk patients. In conclusion, given that there was no LNM in 
patients with MSI-H tumors, MSI status could serve as a 
negative predictive factor in estimating LNM in T1 colorec-
tal cancer. Although this study showed the possibility of 
negative predictive power of MSI-H in LNM, the sample 
size is relatively small. Further large scale studies are re-
quired to confirm our observation. 
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